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Abstract
Background: Malaria is the most important public health problems in tropical and sub-tropical countries. Haem
oxygenase (HO) enzyme and the pro-inflammatory cytokine tumour necrosis factor (TNF) have been proposed as
one of the factors that may play significant role in pathogenicity/severity of malaria infection. HO is the enzyme of
the microsomal haem degradation pathway that yields biliverdin, carbon monoxide, and iron. In this study, the
association between malaria disease pathogenicity/severity and (GT)n repeat polymorphism in the promoter region
of the inducible HO-1 including the effect of cadmium exposure (potent inducer of HO-1 transcription) as well as
polymorphism of TNF were investigated.
Methods: Blood samples were collected from 329 cases non-severe malaria with acute uncomplicated Plasmodium
falciparum malaria (UM) and 80 cases with Plasmodium vivax malaria (VM), and 77 cases with severe or cerebral
malaria (SM) for analysis of genetic polymorphisms of HO-1 and TNF and cadmium levels. These patients consisted
of 123 (25.3%) Thai, 243 (50.0%) Burmese and 120 (24.7%) Karen who were present at Mae Sot General Hospital,
Mae Sot, Tak Province, Thailand.
Results: The number of (GT)n repeats of the HO-1 gene in all patients varied between 16 and 39 and categorized
to short (S), medium (M) and long (L) GTn repeats. The genotype of (GT)n repeat of HO-1 was found to be
significantly different among the three ethnic groups of patients. Significantly higher frequency of S/L genotype
was found in Burmese compared with Thai patients, while significantly lower frequencies of S/S and M/L but
higher frequency of M/M genotype was observed in Burmese compared with Karen patients. No significant
association between HO-1 and TNF polymorphisms including the inducing effect of cadmium and malaria
pathogenicity/severity was observed.
Conclusions: Difference in the expression of HO-1 genotype in different ethnic groups may contribute to different
severity of malaria disease. With this limited sample size, the finding of the lack of association between malaria disease
pathogenicity/severity genetic polymorphisms of HO-1 (GT)n repeat as well as TNF observed in this study may not entirely
exclude their possible link with malaria disease pathogenicity/severity. Further study in larger sample size is required.
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Background
Malaria remains an important health problem in several
countries in the world especially in Thailand [1,2]. Cere-
bral malaria is one of the major pathological complica-
tions of Plasmodium falciparum infection in humans,
manifesting as coma that can lead to death. The patho-
genesis of cerebral malaria remains controversial, but
major factors involved, i.e., cytokines and adhesion
molecules are well documented [3]. In Thailand, malaria
is still problematic in particular areas, especially in the
forest and forest fringes along international borders
where there is significant population movement. The
highest cases of malaria in 2009 were reported from Tak
Province, where Mae Sot District is located. They have
carried the largest burden of malaria diagnosis and
treatment for foreigners, the majority of whom are from
Myanmar [2]. Mae Sot District is also an endemic area
polluted with high levels of cadmium [4-6]. The degree
of soil cadmium contamination is associated with
rice grain cadmium contamination downstream of an
actively mined zone of zinc mineralization in Mae Sot
District [6]. Population cadmium exposure is due mainly
to eating contaminated food, smoking cigarettes, and
occupation in cadmium-contaminated places [7]. There
have been several reports on the involvement of cad-
mium in nephropathy [5,7,8].
Haem oxygenase (HO) enzyme is proposed as one of
the factors that may play role in pathogenesis including
susceptibility and severity of malaria disease [9,10]. The
isoforms HO-1 and HO-2, are microsomal enzymes that
play important role in haem catabolism to produce bili-
verdin/bilirubin, carbonmonoxide and iron [9,11-13].
The promoter region of HO-1 gene contains cadmium
response element (CdRE), the binding site for cadmium
which is a potent inducer of HO-1 transcription [14].
Therefore, it may be possible that the linkage of cad-
mium exposure and susceptibility to malaria disease is
through binding of cadmium to CdRE of the HO-1
gene. The polymorphism of human HO-1 gene promo-
ter compose of the single nucleotide polymorphism
(SNPs) and (GT)n dinucleotide polymorphism which
may contribute to the fine tuning of the transcription.
Long (GT)n alleles have been found associated with sus-
ceptibility to smoking-induced emphysema or coronary
artery disease, while they may be linked to resistance to
cerebral malaria [10,15,16].
TNF is a cytokine produced primarily by monocytes
and macrophages in many inflammatory diseases. SNPs
of the TNF promoter have been reported to be asso-
ciated with susceptibility to severe malaria. Four muta-
tions are transitions of adenosine to guanine and are
located at nucleotide positions -238, -244, -308, and
-376, relative to the transcriptional site [17,18]. Various
studies have investigated the relation existing between
TNF promoter alleles and severity of malaria. TNF has
been shown to be elevated in severe malaria [19], and
TNF promoter region -238A allele together with -376A
allele are associated with susceptibility to severe malaria
[20,21]. Furthermore, TNF P-D allele has been shown
significantly associated with cerebral malaria in our pre-
vious study in Karen and Burmese populations [22].
In this study, the (GT)n repeat polymorphism in the
promoter region of the inducible HO-1 and six muta-
tions of TNF from malaria patients (Thai, Burmese and
Karen), in Mae Sot endemic area, were analysed. The
aim was to determine the association between genetic
polymorphisms of HO-1, TNF and severity of malaria
infection.
Methods
Subjects and blood collection
A total of 486 malaria patients infected with P. falci-
parum and P. vivax (aged between three and 73 years,
parasitaemia ranged from 77 and 1,840,000/μl) com-
prising 123 (25.3%) Thai, 243 (50.0%) Burmese and
120 (24.7%) Karen who were present at Mae Sot
General Hospital, Mae Sot, Tak Province, Thailand,
were recruited into the study. The study protocol was
approved by the Ethics Committee of the Ministry of
Public Health, Thailand. All patients gave informed
consents for study participation prior to the study
enrolment.
Blood samples were collected from 329 cases non-
severe malaria with acute uncomplicated P. falciparum
malaria (UM) and 80 cases with P. vivax malaria (VM),
and 77 cases with severe or cerebral malaria (SM) for
analysis of genetic polymorphisms of HO-1 and TNF
and cadmium levels.
Extraction of genomic DNA
Genomic DNA was extracted from packed white blood
cells (buffy coat layers) using standard phenol-chloro-
form extraction technique [23].
Microsatellite polymorphism
To amplify the (GT)n microsatellite located at position
-270 of HO-1 gene promoter, the PCR assays were
performed over 35 cycles of 30 s at 95°C, 30 s at 60°C,
and 3 min at 72°C. A fluorescently labelled primer p1
(5’-AGAGCCTGCAGCTTCTCAGA-3’) and an unla-
beled antisense primer p2 (5’-ACAAAGTCTGGCCA-
TAGGAC-3’) was designed according to the published
sequence [24]. The PCR products were analysed by a
laser-based automated DNA sequencer, ABI 3730
DNA Analyzer (Applied Biosystems, Foster City, Calif.,
USA).
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Direct sequencing
To analysis of six-biallelic polymorphic sites (TNF-
1,031T/C, -863C/A,-857C/T, -376G/A, -308G/A, and
-238G/A) in the 5’-flanking region of TNF gene, a
1,042-bp DNA fragment spanning the 5’-flanking region
of the TNF gene from position -66 to -1,107 were
amplified by PCR. The primers for the PCR reactions
and the method for direct sequencing followed the
methods described by Higuchi [25] and Ubalee [22].
Analysis of cadmium levels
Cadmium levels in plasma samples collected from 138
patients with malaria (13 cases with SM, 92 cases with
UM and 33 cases with VM) were measured by Graphite
Furnace Atomic Absorption Spectrophotometer
(GFAAS) [26]. Analysis of cadmium in blood was not
possible due to limited blood sample volume. The
threshold level of blood cadmium defined by the World
Health Organization is 0.5 μg/L [27].
Statistical analysis
Statistical analysis was performed using SPSS version
12.0 software (SPSS Co., Ltd., Thailand). Statistical sig-
nificance level for all tests was set at a = 0.05. The fre-
quencies of HO-1 and TNF genotype alleles were
summarized as number of cases and percentage values.
The association between genetic polymorphisms of HO-
1 including TNF and ethnicity and malaria disease
pathogenicity/severity (UM, SM, VM) were determined
using Chi-square test. The concentrations of cadmium
in plasma were presented as median (range) values for
data not conforming to normal distribution. The asso-
ciation between the level of cadmium exposure and
malaria disease pathogenicity/susceptibility/severity was
performed by Kruskal Wallis tests. Difference in propor-
tions among ethic groups and disease pathogenicity/sus-
ceptibility/severity was determined by Chi-square test.
Results
The polymorphism of (GT)n repeat of human HO-1 and
association with malaria disease pathogenicity/
susceptibility/severity
The number of (GT)n repeats of the HO-1 gene varied
between 16 and 39 in all patients (Figure 1). It was cate-
gorized to short (16-27), medium (28-33) and long (34-
39) of GTn repeats. The allele frequencies of (GT)n allele
were similar in the three ethnic groups. With regards to
the frequencies of the genotypes (S/S, S/M, S/L, M/M,
M/L, L/L) of (GT)n repeats (Table 1), significantly higher
frequency of S/L genotype was found in Burmese com-
pared with Thai patients. However, significantly lower
frequencies of S/S and M/L but higher frequency of
M/M genotype was found in Burmese compared with
Karen patients. When data were combined for all ethnic
groups, no association between malaria disease severity
and HO-1 genotype was observed.
The polymorphism of TNF alleles and association with
malaria pathogenicity/susceptibility/severity
The patterns of SNPs in TNF alleles in the three ethnic
groups were observed based on five [22] and three [28]
point mutations as shown in Tables 2 and 3. For the
five SNPs of biallelic polymorphism sites (-1031, -863,
-857, -308, -238), six types of TNF promoter (TNF P)
allele polymorphism were found, i.e., TNF P-A, TNF P-
B, TNF P-C, TNF P-D, TNF P-E and TNF P-F. For the
pattern of three SNPs of biallelic polymorphism sites
(-1031, -863, -857), five types of TNF P allele poly-
morphism were observed, i.e., TNF P-1, TNF P-2, TNF
P-3, TNF P-4 and TNF P-5. There was no significant
difference in the frequencies of each mutation among all
the three ethnic groups. In addition, when data were
combined for all ethnic groups, lack of association
between any pattern of TNF allele polymorphism as
well as each individual single SNP and malaria disease
pathogenicity/severity was found.
Cadmium levels and association with malaria
pathogenicity/susceptibility/severity
When data were combined for the three ethnic groups,
a trend of higher plasma cadmium levels in falciparum
infection [median (range) values of 0.16 (0.03-2.34) and
0.24 (0.01-3.18) μg/L for SM and UM, respectively]
compared with VM [0.10 (0.01-0.33) μg/L], was
observed. In the group with cadmium levels < 0.5 mg/L,
the proportions of patients with SM (n = 10, 76.9%) and
UM (n = 74, 80.4%) were significantly lower than VM
(n = 33, 100%), and in addition, the proportion of Thai
patients (n = 18, 66.7%) was significantly lower than
Burmese (n = 81, 91.0%).
Discussion
The association between human haem oxygenase-1
(HO-1) and pathogenicity/severity of malaria infection
was described in a few studies in vitro including mole-
cular epidemiological investigation from brain lesion
[24,29,30] and the hypothetical roles of HO-1 in patho-
genesis of cerebral malaria was proposed by Shibahara
[10]. However, only one research article which provides
evidence on the association between (GT)n repeat poly-
morphism of HO-1 and malaria pathogenicity/severity
was reported in Karen ethnic minority group with cere-
bral malaria and acute uncomplicated falciparum
malaria who resided in areas along the Thai-Myanmar
border [24]. In that study, the proportion of patients
with short (GT)n alleles was found to be significantly
higher in cerebral malaria (SM) than UM. Short (GT)n
alleles in the promoter region may therefore represent a
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genetic risk factor for cerebral malaria as in may directly
enhance the transcription of HO-1 in malaria patients,
and as a consequence, the products of haem degrada-
tion, i.e., CO, iron and bilirubin, may increase in the
brain lesion. Furthermore, the influence of the (GT)n
repeat polymorphisms in the HO-1 gene promoter was
investigated in different cell lines where constructs with
lengths of less than 25 repeats (short repeat) showed an
increasing HO-1 basal promoter activity [31] or tran-
scriptional up-regulation in response to various stimuli
as compared to that with greater than 25 repeats [15].
Increasing transcriptional up-regulation leads to high
activity of HO-1 enzyme and thus, the haem
degradation products particularly iron, which is an
essential supply for growth and proliferation of malaria
parasite. Excess amount of iron might trigger high para-
sitaemia causing red blood cell haemolysis and severe
malaria including cerebral malaria.
The present study, due to limitation of available data
on (GT)n repeat polymorphism of HO-1 in different
patient populations with different malaria severity, esti-
mation of proper sample size was not possible. There
appears to be a significant difference in HO-1 geno-
types among the three ethnics. This may explain differ-
ence in pathogenicity/severity of malaria infection in
various ethnics. The frequencies of short (GT)n alleles
Figure 1 Frequency distribution of (GT)n repeats in three ethnic groups of patients.
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(S/S) genotype in the three groups of patients with dif-
ferent disease severity (combined ethnics) were found
to be comparable. This lack of association could repre-
sent a genuine finding, or else, a low study power due
to inadequate sample size (particularly in the SM
group). In addition, the major confounding factor eth-
nics cannot be excluded. In a previous study, a signifi-
cant association between the short (GT)n alleles (S/S)
polymorphism of HO-1 gene promoter and increased
risk of cerebral malaria (severe malaria) has been
demonstrated in 150 Burmese and Karen patients [24].
Nevertheless, the sample size included in that study
was unbalanced and also too small (30 cases of cere-
bral malaria, 120 cases of UM) to provide a definitive
conclusion on such association. The finding of the lack
of association between genetic polymorphism of HO-1
(GT)n repeat and malaria disease pathogenicity/severity
found in this study may not entirely exclude the possi-
ble link between HO-1 enzyme activity and malaria
disease pathogenicity/severity. Results from recent
in vitro study provide insight into the molecular
mechanism of induction of HO-1 activity and the link
with malaria pathogenicity/severity [10,24]. Treatment
of astrocyte (CCF-STTG1) and retinal pigment epithe-
lial (ARPE-19, D407) cells with exogenous prostaglan-
din D2 (PGD2) and 15d-PGJ2 (metabolite of PGD2)
consistently induced the expression of HO-1 mRNA
and protein [32,33]. PGD2 is a major prostanoid pro-
duced in the brain and is involved in the regulation of
sleep and pain responses [34].
Cadmium has been shown to be a potent inducer of
HO-1 activity [14,35], and as a consequence, this might
be linked to severity of malaria disease. Blood cadmium
reflects recent cadmium exposure, whereas urinary cad-
mium indicates body accumulation of cadmium [7,36].
The ratio of plasma to blood cadmium varies from 3 to
16% [37]. The observed median (range) values of plasma
cadmium concentrations in the VM, UM and SM
groups of patients were 0.10 (0.01-0.33), 0.24 (0.01-3.18)
and 0.16 (0.03-2.34) μg/L, respectively. Twenty-one
patients (in SM and UM groups) had the concentrations
above the tolerance limit of 0.5 μg/L [38]. The informa-
tion on blood cadmium concentrations in Thai popula-
tion has been reported in non-occupational females
living in Bangkok and other areas, with the geometric
mean blood levels of 0.40 and 0.43 μg/L, respectively
[39]. The observed concentrations of cadmium in
plasma in malaria patients were considered higher than
non-occupational residents in other areas due to the
fact that cadmium level in plasma is only about 3-16%
of that in blood [40]. Although the concentrations of
plasma cadmium are still considered low considering
the threshold level of 0.5 mg/L, results may more or less
explain the high incidence of malaria case report, mor-
tality and morbidity from this high cadmium pollutant
area of Mae Sot. It appears that plasma cadmium
Table 1 Distribution of HO-1 promoter genotypes and
allele frequencies of the three ethnics (Thai, Burmese,
Karen) of malaria patients
Ethnic
Thai Burmese Karen
n 119 240 118
Alleles, n (%)
S 132 (55.5%) 236 (49.2%) 133 (56.4%)
M 93 (39.1%) 205 (42.7%) 81 (34.3%)
L 13 (5.5%) 39 (8.1%) 22 (9.3%)
Genotypes, n (%)
S/S 39 (32.8%) 57 (23.8%)a 40 (33.9%)
S/M 50 (42.0%) 97 (40.4%) 45 (38.1%)
S/L 4 (3.4%)b 25 (10.4%) 8 (6.8%)
M/M 18 (15.1%) 49 (20.4%)c 12 (10.2%)
M/L 7 (5.9%) 10 (4.2%)d 12 (10.2%)
L/L 1 (0.8%) 2 (0.8%) 1 (0.8%)
a p = 0.042, 95% CI of odd ratio: 0.37-0.98 for Burmese vs Karen (Chi-square
test)
b p = 0.021, 95% CI of odd ratio: 0.10-0.88 for Thai vs Burmese (Chi-square
test)
c p = 0.015, 95% CI of odd ratio: 1.15-4.45 for Burmese vs Karen (Chi-square
test)
d p = 0.026, 95% CI of odd ratio: 0.16-0.92 for Burmese vs Karen (Chi-square
test)
Table 2 Six TNF alleles polymorphism (TNF P-A, TNF P-B, TNF P-C, TNF P-D, TNF P-E, TNF P-F) based on five SNPs of
biallelic polymorphism sites (-238, -308, -857, -863, -1031) in patients with severe (SM), uncomplicated falciparum
(UM) and vivax malaria (VM) cases when data were combined for the three ethnic groups
TNF type Polymorphic sites of the promoter region of TNF-a gene SM UM VM
-238 -308 -857 -863 -1031 (%) (%) (%)
TNFP-A G G C C T 41.3 52.3 53.5
TNFP-B G G C A C 39.7 33.8 33.8
TNFP-C A G C C C 3.2 3.3 4.2
TNFP-D G G T C T 6.3 4.3 3.5
TNFP-E G A C C T 7.9 5.0 3.5
TNFP-F G G C A T 1.6 1.3 1.4
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concentrations tended to be higher in patients with fal-
ciparum malaria (UM and SM) compared with VM. In
addition, significantly lower proportions of cases with
falciparum malaria including both UM (80.4%) and SM
(76.9%) were found compared with VM (100%) at
plasma cadmium level of ≤ 0.5 μg/L. Cadmium is
known to produce toxic effect to human and other
organisms including malaria parasite when exposing
with high level of cadmium. It is possible that optimally
high levels of cadmium might promote the growth of
P. falciparum but not with P. vivax by inducing HO-1
activity to produce iron. The mechanism(s) by which
parasite transport or demolish cadmium are, therefore,
important for their survival. It has been reported that
P. falciparum efflux cadmium from cells through
PFMDR2 protein [41]. Again, due to limited sample size
and confounding factors (age, gender, ethnic), definitive
conclusion on this association could not be obtained.
Cadmium concentrations have been reported to vary
markedly according to age, gender and ethnic [42,43]
and results from the present study also revealed some
association between ethnicity (Thai vs Burmese) and
cadmium levels in group with level of ≤ 0.5 μg/L.
Several articles have reported the involvement of cyto-
kines in the histopathology of cerebral malaria [44,45].
Among these cytokines, TNF is thought to play a major
role in pathogenesis of cerebral malaria. Others have
reported the presence of cytokines in the brain after
fatal cases of malaria [45,46]. Three SNPs of TNF pro-
moter -857, -863 and -1031 were analyzed and the fre-
quency of the designated allele -857C/-863C/-1031C
was found to be significantly higher in patients with cer-
ebral malaria than that with UM in area along Thai-
Myanmar border [28]. In the present study, the fre-
quency of -857C/-863C/-1031C was found to be 1.3, 4.0
and 3.1% in Thai, Burmese and Karen patients, respec-
tively. It was noted however for the observed lack of sig-
nificant difference in frequency of this promoter allele
(-857C/-863C/-1031C) between the SM and UM groups.
The TNF polymorphism was categorized based on the
patterns of allele polymorphisms reported by Ubalee
[22] and Hananantachai [28]. The first classification–
TNF P-A, TNF P-B, TNF P-C, TNF P-D, TNF P-E and
TNF P-F was based on the biallelic polymorphism sites
at nucleotides -238, -308, -857, -863 and -1031. The sec-
ond classification– TNF P1, TNF P-2, TNF P-3, TNF
P-4 and TNF P-5 was based on the biallelic polymorph-
ism sites at nucleotides -857, -863 and -1031. No signifi-
cant association between any pattern of TNF
polymorphism as well as each individual single SNPs
and disease pathogenicity/severity (SM, UM, VM)
including ethnics (Thai, Karen, Burmese) were observed
when polymorphisms were classified based on both cri-
teria. The biallelic polymorphic sites at nucleotides -238,
-308, -857, -863 and -1031, with seven allele patterns
(TNF P-A, TNF P-B, TNF P-C, TNF P-D, TNF P-M1,
TNF P-M4 and TNF P-M7) were identified in a pre-
vious study in Burmese and Karen patients who lived
near Thai-Myanmar border [22] and TNF P-D allele
was found to be significantly associated with the high
proportion of cerebral malaria (SM) compared with UM
cases. Interestingly, the TNF P-M1, TNF P-M4 and
TNF P-M7 but TNF P-E and TNF P-F were not found
in all the three ethnics under the present investigation.
The frequencies of the -863C or -1031T allele, the typi-
cal polymorphisms of TNF P-D, were found much
higher in Swedish (94% for -863C and 80% for -1031T)
[47] and in Japanese (82% for -863C and 84% for
-1031T) subjects [25] than in the three ethnics under
present investigation where the frequencies of -863C
and -1031T alleles were 38 vs 39% in Thai, 40 vs 38% in
Burmese and 41 vs 40% in Karen patients, respectively.
The association of single SNP of TNF was also found in
other studies in African patients. Two studies were per-
formed in Gambian children and results showed that
the TNF -238 A allele was found to be associated with
susceptibility to severe malarial anaemia but not to CM
[20]. On the other hand, the neighbouring TNF -308 A
allele was associated with CM but not with severe
malarial anaemia [48]. Furthermore, data from 1,048
Kenyan children showed the TNF -308 A allele to be
significantly associated with high density P. falciparum
parasitaemia. Among low birth weight children, the
TNF -308 A allele was also found to be associated with
Table 3 Five TNF alleles polymorphism (TNF P-1, TNF P-2, TNF P-3, TNF P-4, TNF P-5) based on three SNPs of biallelic
polymorphism sites (-857, -863, -1031) in patients with severe (SM), uncomplicated falciparum (UM) and vivax malaria
(VM) cases when data were combined for the three ethnic groups
TNF type Polymorphic sites of the promoter region of TNF-a gene SM UM VM
-857 -863 -1031 (%) (%) (%)
TNFP-1 C C T 49.2 57.2 57.7
TNFP-2 T C T 6.3 4.3 3.5
TNFP-3 C A C 39.7 34.5 34.5
TNFP-4 C C C 3.2 3.0 3.5
TNFP-5 C A T 1.6 1.0 0.7
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severe anaemia with a trend toward a risk for severe
malaria anaemia [49]. In contrast with other studies, a
study conducted in Gabon comparing malaria severity
and TNF promoter (TNF P) variants has demonstrated
that the frequencies of carriers of distinct TNF variants
did not differ significantly in the groups with mild and
SM [18]. Moreover, TNF plasma levels were not signifi-
cantly associated with any of the TNF variants.
Conclusions
Difference in the expression of HO-1 genotype in differ-
ent ethnic groups may contribute to different severity of
malaria disease. To definitely conclude on the associa-
tion between malaria pathogenicity/severity and the
involvement of genetic polymorphisms of HO-1 (includ-
ing the inducing effect of cadmum) and TNF, further
study with larger sample size estimation based on this
preliminary data should be performed with focus on
only one ethnic group (Burmese patients, which consti-
tute the majority group of patients in this area).
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